Passage Bio, Inc.PASGNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-33.51%
↑ 84% vs avg
Percentile
P29
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-210.63%
Historical baseline
PeriodValue
Q4 2025-33.51%
Q3 202523.33%
Q2 202554.29%
Q1 2025-63.99%
Q4 2024-13.39%
Q3 202443.31%
Q2 202430.60%
Q1 20243.01%
Q4 2023-1.84%
Q3 2023-11.81%
Q2 202323.64%
Q1 20236.56%
Q4 2022-2.68%
Q3 202210.31%
Q2 202241.66%
Q1 2022-45.28%
Q4 202125.04%
Q3 2021-68.75%
Q2 202120.80%
Q1 2021-4.40%
Q4 2020-67.85%
Q3 2020-49.64%
Q2 202046.39%
Q1 2020-25.02%
Q4 2019-52.99%
Q3 2019-5.97%
Q2 2019-4937.38%
Q1 2019-1052.58%
Q4 20180.00%